(n.) A kind of customary payment by a tenant; -- a word used in old records.
Example Sentences:
(1) In 6 cases of T cell lymphoma, 5 cases were positive for T3+ and Tac+ each; 4 for T11+ and 2 for T6+ while all were positive for T4 and negative or weakly positive for T8A.
(2) The tetracaine component of TAC is superfluous for obtaining topical anesthesia of minor dermal lacerations of the face in children.
(3) The response of Tac rosette positive cells to recombinant IL-2 was always higher than that of the Tac rosette negative or unselected cells, indicating that this rosette method specifically selects T cells expressing IL-2 receptor.
(4) The role of interleukin 2 (IL-2) in the activation of suppressor T cells was investigated by using the monoclonal antibody anti-Tac, which blocks the binding of IL-2 to the 55-kDa peptide of the high-affinity IL-2 receptor.
(5) The IL 2 receptor on T4+ T-CLL cells was indistinguishable from that on normal activated T cells with respect to molecular weight and downregulation by the anti-Tac antibody.
(6) The capacity for T cell proliferation and the expression of Tac antigen (IL-2 receptor) was assessed during the post-burn period in patients with injuries ranging from 5-68% total body surface area.
(7) Comparison with the respective wild-type nucleotide sequence shows only one nucleotide change, G----A, causing a replacement of cysteine-58 (TGC) with tyrosine (TAC) in the E3 protein of ts1.
(8) A procedure is described for the phagocytic labeling of white blood cells (WBC) with high specific activity 99mTc--albumin colloid (TAC).
(9) Both the neuA and neuC genes are coexpressed under the control of a single upstream T7 or tac promoter, suggesting that neuA and neuC are part of an operon.
(10) The addition of anti-Tac during a preculture period inhibited the generation of Epstein-Barr virus (EBV)-induced suppressor T cells and of suppressor T cells induced in an antigen-specific system by a high antigen (sheep red blood cell) concentration.
(11) In contrast to wild-type IL-2R alpha, shedding of mutant Tac protein is strongly reduced.
(12) The complete transcriptional unit, incorporating the tac promoter and rrnB transcription terminators flanking the Pf1 coat protein gene, was excised from the expression plasmid and cloned into the intergenic space of bacteriophage R252, an fd bacteriophage that carries an amber mutation in its own major coat protein gene.
(13) The time course of expression of other known activation antigens, such as Tac and transferrin receptor, was comparable to that of CK226.
(14) In previous work, our laboratory has molecularly cloned the cDNA coding for the bovine IL-2 and IL-2R (p55, Tac) proteins.
(15) The degree of inhibition of protein synthesis, however, was not closely correlated with expression of CD25 antigen (low-affinity Mr 55,000 glycoprotein, IL-2R, Tac antigen) on ATL cells.
(16) Unlike other reported cases of Thp-CLL, fresh leukemic cells from this patient were positive with the anti-Tac monoclonal antibody, which recognizes the receptor for interleukin-2 (IL-2).
(17) SF CD4+ cells from RA and non-RA arthritides expressed the Tac antigen much more frequently than corresponding CD8+ cells (54 and 58% versus 16 and 17%).
(18) A Tn5tac1 insertion just inside the 3' end of cysQ, with its isopropyl-beta-D-thiogalactopyranoside-inducible tac promoter pointed toward the cysQ promoter, resulted in auxotrophy only when isopropyl-beta-D-thiogalactopyranoside was present; this conditional phenotype was ascribed to collision between converging RNA polymerases or interaction between complementary antisense and cysQ mRNAs.
(19) In addition, a monoclonal antibody (moAb) against the IL2 receptor (IL2-R; anti-Tac) inhibited the spontaneous colony formation from T-CFC of both groups of patients.
(20) The artificial secretory molecule of the IL-2 receptor named "bottom-less" receptor was able to react with anti-Tac antibody and to bind IL-2.
Tace
Definition:
(n.) The cross, or church, of St. Antony. See Illust. (6), under Cross, n.
(n.) See Tasse.
Example Sentences:
(1) Sixty-six consecutive patients with unresectable hepatocellular carcinoma (HCC) were treated with transcatheter arterial chemoembolization (TACE) using aclarubicin microspheres (ACRms) in combination with cisplatin suspended in iodized oil (Lipiodol, Laboratoire Guerbert, Paris, France) (CSL).
(2) A reduction of the tumor size after L-TACE did not necessarily mean a good prognosis for the patients.
(3) We investigated the incidence and endoscopic features of gastroduodenal lesions which appeared after transcatheter arterial chemo-embolization (TACE), performed 29 times in 25 patients with inoperative hepatocellular carcinoma.
(4) The single oral dose of quinestrol showed efficacy equal to the 2-day regimen of Tace.
(5) Therefore, we would like to recommend, TACE of HCC in well-selected patients presenting with good clinical status, patency of the portal vein and without broken capsule, in order to achieve better clinical results.
(6) 3) When ADM was dissolved in Gd-DTPA and intraarterially infused without being mixed with lipiodol, the intensity of the signal on MRI was the same as that in LP-TACE immediately after the administration, and gradually decreased thereafter.
(7) The results demonstrated that TACE can be effective for humoral hypercalcemia of HCC.
(8) These results suggest that TACE is more effective than oral chemotherapy for treatment of hepatocellular carcinoma that recurs after partial hepatectomy.
(9) Further follow-up studies will be needed to discover the effects of oral chemotherapy after L-TACE.
(10) The new development or exacerbation of the gastroduodenal lesions after TACE was evident in 13 of the 29 (45%).
(11) In 22% of the HCC patients and in 42% of the metastatic liver cancer patients, the tumor size was reduced by more than 50% after L-TACE.
(12) Transcatheter arterial chemoembolization (TACE) is one of the established therapeutic modalities for treatment of metastatic liver cancer originating in the gastrointestinal tract.
(13) The factors relating to the duration of survival were analyzed for 329 cases of hepatocellular carcinoma (HCC) treated by transcatheter arterial chemoembolization (TACE) between January 1, 1983, and December 31, 1990.
(14) The marked antiestrogen character of TACE was surprising since TACE has been classified and clinically used as an estrogen.
(15) In light of these events, upper gastrointestinal endoscopy should be added to the usual examinations done for patients undergoing TACE.
(16) Cis-Diamminedichloroplatinum (CDDP)-lipiodol suspension (CLS) was developed as a transarterial chemoembolization (TACE) material.
(17) The materials were then clinically prescribed as an embolic agent in preoperative TACE for patients with locally advanced breast cancer.
(18) Under adequate medical care, TACE can safely be applied, although there are some reports about fatal complications.
(19) The survival rates of the HCC patients after L-TACE did not change as a result of oral 5-fluorouracil administration.
(20) TAM and TACE acted as partial agonists on PRL and uterine weight induction.